Gentium S.p.A. (NASDAQ:GENT)(AMEX:GNT) (the Company) today announced that its American Depository Shares (ADSs) will be listed and begin trading today on the NASDAQ National Market System under...
Gentium S.p.A. (AMEX: GNT) (the Company) today announced that effective May 16, 2006, the Company's American Depository Shares (ADSs) will be listed for trading on The NASDAQ National Market...
Gentium S.p.A. (AMEX:GNT) (the "Company") today reported financial results for the quarter and year ended December 31, 2005. Highlights of the fourth quarter of 2005 and recent weeks as of...
Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Beth Israel Deaconess Medical Center and The Children's Hospital Receive IRB Approval to Commence Study ? Gentium S.p.A...
Gentium S.p.A. (AMEX:GNT) (the "Company") today reported that on February 7, 2006, Guenther Eisser, Chief of Biology Research for Gentium, will present a poster entitled, "Defibrotide...
Gentium S.p.A. (AMEX:GNT) (the "Company") today reported that an independent study of Defibrotide was the subject of a published paper titled "Successful Treatment with Defibrotide for Sinusoidal...
Gentium S.p.A. (AMEX:GNT) (the "Company") today announced the initiation of a Phase II/III trial with Defibrotide to prevent Veno-Occlusive Disease ("VOD"), a complication of bone marrow and stem...
Gentium S.p.A. (AMEX:GNT) (the "Company") today reported financial results for the three- and nine-month periods ended September 30, 2005. Highlights of the third quarter of 2005 and recent weeks...
Gentium S.p.A. (AMEX:GNT) (the "Company") announced today that Laura Ferro, M.D., Chairman and Chief Executive Officer of Gentium, will present a corporate update at the upcoming Rodman & Renshaw...
Gentium S.p.A. (AMEX:GNT) (the "Company") announced today that it has completed its previously announced $10.9 million private placement of 1,551,125 of its American Depository Shares (ADSs) at a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.